Viva Biotech has a high-level professional team focused on preclinical macromolecular drug discovery, and world-class comprehensive antibody discovery technology platforms. In addition to traditional hybridoma screening technologies, we also have optimized phage display technology, yeast display technology, and mammalian cell display technology, etc., providing one-stop services in macromolecule R&D from target antigens to functional antibody candidates for domestic and international pharmaceutical and biotechnology companies.
Design, expression and purification of target antigen
Assembly design and preparation of Nano-disc and VLP antigens
Stable cell lines generation of Target
Screening of human specific antibodies
Screening of nanobody/VHH and humanized single chain antibody
Screening of monoclonal antibodies in mice and rats
Identification of binding or blocking activity against protein or on cells)
(Identification of internalization of antibodies)
Assay development and characterization of ADCC, CDC, and ADCP
Cytotoxicity test for ADC drug
VH/VL Sequencing
Antibody Humanization
Antibody Affinity Maturation
Antibody production and characterization for chimeric or humanized antibody
Epitope mapping through HDX analysis, antigen/antibody complex crystallization study
Bioactivity & developability
Affinity analysis
Construction of stable cell lines
Stable cell line optimization
For more information about Antibody Drug R&D service.please contact our team
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号